Literature DB >> 2040653

Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease.

M Aoyagi1, N Fukai, H Sakamoto, T Shinkai, Y Matsushima, M Yamamoto, K Yamamoto.   

Abstract

Progressive stenosis or occlusion of bilateral internal carotid arteries by fibrocellular intimal thickening results in cerebral ischemia in moyamoya disease. The etiology is unknown. We examined cultured arterial smooth muscle cells (SMC) from scalp arteries of five patients with moyamoya disease. In this study we investigated the responsiveness of the cells in culture to serum mitogens including platelet-derived growth factor (PDGF), a major mitogen of SMC, and compared the response to that of cells derived from age-matched control patients. SMC from patients with moyamoya disease proliferated less rapidly in a medium with 15% serum than did control SMC and responded poorly to the addition of PDGF to 5% serum. PDGF alone did not stimulate SMC in a quiescent state to initiate DNA synthesis in moyamoya disease, without serum factors other than bovine serum albumin, though it significantly stimulated the controls. Simultaneous additions of epidermal growth factor, insulin-like growth factor-I, and PDGF stimulated initiation of DNA synthesis in cells from moyamoya disease, but not as much as PDGF alone did in the controls. Although direct correlations with the pathogenesis of the disease remain to be clarified, the results indicate altered interrelations between serum factors and the cellular responses in vessels of moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040653     DOI: 10.1002/jcp.1041470202

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Steal phenomenon through the anterior communicating artery in Moyamoya disease.

Authors:  Soo Mee Lim; Eun Jin Chae; Min Yeong Kim; Jae Kyun Kim; Sang Joon Kim; Choong Gon Choi; Jae Sung Ahn; Young-Shin Ra; Jong-Uk Kim; Kyung Don Hahm; Hae Wook Pyun; Dae Chul Suh
Journal:  Eur Radiol       Date:  2006-05-24       Impact factor: 5.315

2.  Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.

Authors:  Constantin Roder; Vera Peters; Hidetoshi Kasuya; Tsutomu Nishizawa; Yayoi Takehara; Daniela Berg; Claudia Schulte; Nadia Khan; Marcos Tatagiba; Boris Krischek
Journal:  Childs Nerv Syst       Date:  2010-08-06       Impact factor: 1.475

Review 3.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

4.  Organization of F-actin filaments in human glioma cell lines cultured on extracellular matrix proteins.

Authors:  N Nagano; M Aoyagi; K Hirakawa; M Yamamoto; K Yamamoto
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 5.  Cell biology of human vascular smooth muscle.

Authors:  P Chan
Journal:  Ann R Coll Surg Engl       Date:  1994-09       Impact factor: 1.891

6.  Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.

Authors:  Toshiyuki Amano; Satoshi Inoha; Chun-Ming Wu; Toshio Matsushima; Kiyonobu Ikezaki
Journal:  Childs Nerv Syst       Date:  2003-07-25       Impact factor: 1.475

Review 7.  Single Nucleotide Polymorphism in Patients with Moyamoya Disease.

Authors:  Young Seok Park
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 8.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

9.  Off-pump coronary artery bypass grafting in moyamoya disease.

Authors:  Do-Kyun Kim; Kyung-Jong Yoo
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

Review 10.  A new horizon of moyamoya disease and associated health risks explored through RNF213.

Authors:  Akio Koizumi; Hatasu Kobayashi; Toshiaki Hitomi; Kouji H Harada; Toshiyuki Habu; Shohab Youssefian
Journal:  Environ Health Prev Med       Date:  2015-12-10       Impact factor: 3.674

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.